Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Pfirrmann

Comment on "Second-Generation Tyrosine Kinase Inhibitors Improve the Survival of Patients With Chronic Myeloid Leukemia in Whom Imatinib Therapy Has Failed" Haematologica 2011;96(12):1779-82

Haematologica
Hematology
2012English

Related publications

Use of Second Generation Tyrosine Kinase Inhibitors for Second-Line Treatment of Chronic Myeloid Leukemia After Imatinib Failure

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2011English

Arterial Events in Patients With Chronic Myeloid Leukemia Receiving Treatment With Second Generation Tyrosine Kinase Inhibitors

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

The Management of Chronic Myeloid Leukemia in the Era of Second Generation Tyrosine Kinase Inhibitors

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
OncologyHematology
2016English

Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase

Revista de Chimie
SurfacesMaterials ScienceEngineeringMaterials ChemistryFilmsCoatingsChemistry
2019English

Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Thyroid Dysfunction Caused by Second-Generation Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2010English

EVI-1 Oncogene Expression Predicts Survival in Chronic-Phase CML Patients Resistant to Imatinib Treated With Second-Generation Tyrosine Kinase Inhibitors

Blood
BiochemistryImmunologyCell BiologyHematology
2010English

Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Managing Chronic Myeloid Leukemia Patients Intolerant to Tyrosine Kinase Inhibitor Therapy

Blood Cancer Journal
OncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy